MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,276 | -48.8% | 3,857 | -18.9% | 1.18% | -30.6% |
| Q2 2023 | $1,099,098 | -14.5% | 4,758 | -10.4% | 1.70% | -9.3% |
| Q1 2023 | $1,285,916 | -22.4% | 5,308 | -7.0% | 1.88% | -11.0% |
| Q4 2022 | $1,656,167 | +251.6% | 5,706 | -21.3% | 2.11% | +355.7% |
| Q3 2022 | $471,000 | -9.6% | 7,249 | -0.5% | 0.46% | -3.3% |
| Q2 2022 | $521,000 | – | 7,284 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,425,000 | $113,701,000 | 1.79% |
| L1 Capital Pty Ltd | 164,860 | $13,154,000 | 1.64% |
| ARMISTICE CAPITAL, LLC | 1,036,000 | $82,662,000 | 1.40% |
| Tao Capital Management LP | 51,396 | $4,101,000 | 1.09% |
| Parkman Healthcare Partners LLC | 31,393 | $2,505,000 | 0.63% |
| Baker Brothers Advisors | 1,499,213 | $119,622,000 | 0.52% |
| Rock Springs Capital Management LP | 262,500 | $20,945,000 | 0.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 38,500 | $3,072,000 | 0.38% |
| Capital Impact Advisors, LLC | 11,775 | $940,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 73,936 | $5,899,000 | 0.31% |